Skip to content

ALC

Alcon AG

NYSE · Healthcare · Medical - Instruments & Supplies · CH

$65.04
−0.21%
Ask drillr

Year over year

Reported trailing growth

Revenue
+7.8%
EBITDA
-15.9%
EBIT
-26.0%
EPS
-40.1%
Free cash flow
+9.1%
Operating cash flow
+9.6%

Forward estimates

Based on analyst estimates

Revenue
+6.5%
EBITDA
+68.3%
EPS
+188.7%

Three-year CAGR

Revenue
+6.1%
EBITDA
+9.8%
EBIT
+26.5%
Net income
+43.0%
EPS
+43.0%
Free cash flow
+50.5%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026